Aurinia Pharmaceuticals Files 2024 10-K
Ticker: AUPH · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1600620
| Field | Detail |
|---|---|
| Company | Aurinia Pharmaceuticals Inc. (AUPH) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Aurinia Pharma dropped its 2024 10-K. Full year results are in.
AI Summary
Aurinia Pharmaceuticals Inc. filed its 2024 10-K on February 27, 2025, detailing its fiscal year ending December 31, 2024. The company operates in the pharmaceutical preparations sector, with its principal executive offices located in Edmonton, Alberta, Canada. Key financial data and business operations for the fiscal year are outlined in this comprehensive report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Aurinia Pharmaceuticals' financial performance, strategic initiatives, and risk factors for the fiscal year 2024, crucial for understanding the company's current standing and future outlook.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Aurinia faces inherent risks related to drug development, regulatory approvals, market competition, and intellectual property.
Key Numbers
- 2024-12-31 — Fiscal Year End (The end date for the reporting period covered by the 10-K.)
- 2025-02-27 — Filing Date (The date Aurinia Pharmaceuticals submitted its 10-K to the SEC.)
Key Players & Entities
- Aurinia Pharmaceuticals Inc. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end
- 2025-02-27 (date) — Filing date of the 10-K
- Edmonton, Alberta, Canada (location) — Location of company's business and mailing address
FAQ
What is the primary business of Aurinia Pharmaceuticals Inc. as indicated in the filing?
Aurinia Pharmaceuticals Inc. is primarily involved in the Pharmaceutical Preparations industry, as indicated by its SIC code [2834].
When did Aurinia Pharmaceuticals Inc. file its 10-K report for the fiscal year 2024?
Aurinia Pharmaceuticals Inc. filed its 10-K report for the fiscal year 2024 on February 27, 2025.
Where are Aurinia Pharmaceuticals Inc.'s principal business and mailing addresses located?
Aurinia Pharmaceuticals Inc.'s business and mailing addresses are both located at #140, 14315 - 118 AVENUE, EDMONTON, A0 T5L 4S6.
What is the Central Index Key (CIK) for Aurinia Pharmaceuticals Inc.?
The Central Index Key (CIK) for Aurinia Pharmaceuticals Inc. is 0001600620.
What is the SEC file number assigned to Aurinia Pharmaceuticals Inc.?
The SEC file number assigned to Aurinia Pharmaceuticals Inc. is 001-36421.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Aurinia Pharmaceuticals Inc. (AUPH).